Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ 31,388	$ (107,166)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	12,148	12,028
Amortization of deferred debt issuance costs	4,558	3,404
Amortization	41,724	39,754
Stock-based compensation	18,334	15,972
Deferred income taxes	(891)	38,442
Non-cash adjustment to fair value of contingent consideration liability	6,949	0
Loss on early extinguishment of debt	0	3,426
Loss on convertible notes conversion premium	0	103,125
Loss on convertible notes hedge transactions settlement	0	5,460
Increase (decrease) in cash flows from changes in assets and liabilities:
Accounts receivable	(38,015)	(16,092)
Inventories	5,286	(52,126)
Accounts payable	8,133	14,475
Accrued compensation and benefits	5,461	(8,261)
Other assets	(21,978)	(11,710)
Other liabilities	(4,144)	4,232
Net cash provided by operating activities	68,953	44,963
Cash flows from investing activities:
Purchases of property, plant and equipment	(14,177)	(16,109)
Payments related to business acquisitions, net of cash acquired	0	(227,102)
Other	(1,000)	0
Net cash used in investing activities	(15,177)	(243,211)
Cash flows from financing activities:
Payments on term loan	0	(92,981)
Payments on revolving line of credit	(560,000)	(404,000)
Proceeds from revolving line of credit	512,000	317,000
Payments to redeem convertible notes	0	(275,000)
Proceeds from issuance of convertible notes	0	800,000
Payments related to debt issuance costs	0	(21,830)
Dividends paid on common stock	(18,353)	(17,865)
Purchases of convertible notes hedge transactions	0	(187,600)
Proceeds from issuance of warrants	0	72,000
Proceeds from settlement of convertible notes hedge transactions	0	86,228
Payment for settlement of warrants	0	(69,534)
Other, net	14,687	7,067
Net cash provided by (used in) financing activities	(51,666)	213,485
Effect of exchange rate changes on cash and cash equivalents	(550)	(2,730)
Net increase in cash and cash equivalents	1,560	12,507
Cash and cash equivalents at beginning of period	28,942	20,847
Cash and cash equivalents at end of period	30,502	33,354
Non-cash investing and financing activities:
Contingent consideration	0	183,914
Dividends payable	$ 6,149	$ 6,095